NFKB1 and glioblastoma: Epidermal growth factor receptor (EGFR) signalling activates NF‐κB because EGFR gene amplification and mutation are common in GBM, and the aberrant EGFR signalling is likely to be a vital mechanism of NF‐kB activation in GBM.12, 13, 14